New data highlight potential benefit of SPINRAZA® (nusinersen) in infants and toddlers with unmet medical needs after gene therapyPRNewsWire • 06/30/23
Ionis Pharmaceuticals (IONS) Up 19.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/02/23
Here's What Key Metrics Tell Us About Ionis Pharmaceuticals (IONS) Q1 EarningsZacks Investment Research • 05/03/23
Earnings Preview: Ionis Pharmaceuticals (IONS) Q1 Earnings Expected to DeclineZacks Investment Research • 04/26/23
FDA approves QALSODY™ (tofersen) as the first treatment targeting a genetic cause of ALSPRNewsWire • 04/25/23
Eplontersen halted ATTRv-PN disease progression and improved neuropathy impairment and quality of life in Phase 3 study through 66 weeksPRNewsWire • 04/24/23
Ionis And Biogen: Tofersen PDUFA Looms - Positive Outcome May Kick Off Bull Run For Both StocksSeeking Alpha • 04/06/23
New data presented at AD/PD™2023 show IONIS-MAPT Rx (BIIB080) substantially reduced tau protein in patients with early-stage Alzheimer's diseasePRNewsWire • 03/29/23